1. Home
  2. RNAC

as 02-14-2025 10:42am EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Founded: 2007 Country:
United States
United States
Employees: N/A City: FREDERICK
Market Cap: 496.8M IPO Year: 2016
Target Price: $41.67 AVG Volume (30 days): 64.9K
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -23.08 EPS Growth: N/A
52 Week Low/High: $11.67 - $41.87 Next Earning Date: 03-06-2025
Revenue: $47,938,000 Revenue Growth: -62.40%
Revenue Growth (this year): 56.02% Revenue Growth (next year): -86.17%

RNAC Daily Stock ML Predictions

Stock Insider Trading Activity of Cartesian Therapeutics Inc. (RNAC)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
SPRINGER TIMOTHY A RNAC Director10% Owner Jan 13 '25 Buy $17.55 20,967 $366,353.71 8,518,457
English Emily RNAC Chief Operations Officer Jan 3 '25 Sell $16.78 1,797 $30,149.19 40,226
Kurtoglu Metin RNAC Chief Technology Officer Jan 3 '25 Sell $16.78 4,875 $81,790.38 62,258
Davis Blaine RNAC Chief Financial Officer Jan 3 '25 Sell $16.78 7,989 $134,035.55 94,811
Jewell Christopher M RNAC Chief Scientific Officer Jan 3 '25 Sell $16.78 2,550 $42,782.69 53,490
Miljkovic Milos RNAC Chief Medical Officer Jan 3 '25 Sell $16.78 1,880 $31,541.74 36,341
Brunn Carsten RNAC President and CEO Jan 3 '25 Sell $16.78 17,271 $289,764.43 204,096
SPRINGER TIMOTHY A RNAC Director10% Owner Dec 19 '24 Buy $18.52 52,189 $965,020.79 8,518,457
Kurtoglu Metin RNAC Chief Technology Officer Dec 9 '24 Sell $25.15 13,664 $345,133.86 62,258
Kurtoglu Metin RNAC Chief Technology Officer Nov 19 '24 Sell $17.88 38,689 $649,029.56 62,258

Share on Social Networks: